ArticleCancer immunology, immunotherapy : CII2012

The immune inhibitory receptor osteoactivin is upregulated in monocyte-derived dendritic cells by BCR-ABL tyrosine kinase inhibitors.

Mark-Alexander Schwarzbich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.